[
    [
        {
            "time": "2019-12-09",
            "original_text": "['AbbVie', '(ABBV)', 'Dips', 'More', 'Than', 'Broader', 'Markets:', 'What', 'You', 'Should', 'Know']",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Dips",
                    "Broader Markets"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-12-09",
            "original_text": "['World's', 'largest', 'biotech', 'company', 'to', 'move', 'up', 'to', \"BioMed's\", 'big', 'South', 'City', 'project']",
            "features": {
                "keywords": [
                    "World's largest biotech",
                    "move up",
                    "BioMed",
                    "South City project"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "World's largest biotech company to move up to BioMed's big South City project",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-12-09",
            "original_text": "['J&J', 'Presents', 'Data', 'on', 'CAR-T', 'Therapy', 'Drug', 'and', 'Imbruvica', 'at', 'ASH']",
            "features": {
                "keywords": [
                    "J&J",
                    "CAR-T Therapy",
                    "Imbruvica",
                    "ASH"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "J&J Presents Data on CAR-T Therapy Drug and Imbruvica at ASH",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-09",
            "original_text": "['Sanofi', 'to', 'Buy', 'Synthorx', 'for', '$2.5B', 'to', 'Boost', 'Cancer', 'Portfolio']",
            "features": {
                "keywords": [
                    "Sanofi",
                    "Synthorx",
                    "$2.5B",
                    "Cancer Portfolio"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Sanofi to Buy Synthorx for $2.5B to Boost Cancer Portfolio",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-12-09",
            "original_text": "['3', 'Top', 'Dividend', 'Stocks', 'to', 'Maximize', 'Your', 'Retirement', 'Income', '-', 'December', '09,', '2019']",
            "features": {
                "keywords": [
                    "Top Dividend Stocks",
                    "Maximize Retirement Income"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "3 Top Dividend Stocks to Maximize Your Retirement Income - December 09, 2019",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 2,
                "Headline_Structure": 8,
                "Source_Recency": 2
            }
        },
        {
            "time": "2019-12-09",
            "original_text": "['Adaptive', 'and', 'AbbVie', 'Partner', 'Across', 'Multiple', 'Myeloma', 'Trials', 'to', 'Measure', 'Minimal', 'Residual', 'Disease', 'Using', 'the', 'clonoSEQ®', 'Assay']",
            "features": {
                "keywords": [
                    "Adaptive",
                    "AbbVie",
                    "Multiple Myeloma Trials",
                    "clonoSEQ® Assay"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-09",
            "original_text": "['AbbVie', 'and', 'Scripps', 'Research', 'announce', 'collaboration', 'to', 'develop', 'a', 'broad', 'range', 'of', 'new', 'therapeutics']",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Scripps Research",
                    "collaboration",
                    "new therapeutics"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]